Real-world effects of incretin-based Obesity medications on body composition [0.03%]
基于肠泌素的肥胖药物对体成分的实际影响
Rahila Bhatti,Amena Sadiya,Bashair M Mussa et al.
Rahila Bhatti et al.
Background: This study evaluated the real-world impact of incretin-based obesity medications Semaglutide and Tirzepatide on body composition in people with obesity. The primary outcomes included changes in weight, waist c...
Jarvis C Noronha,Luc F Van Gaal,Ian J Neeland et al.
Jarvis C Noronha et al.
Background: Glucagon-like peptide-1 (GLP-1) therapies are highly effective for weight loss and metabolic improvement in obesity and type 2 diabetes management. However, their use poses clinical challenges, including loss ...
An obesity care curriculum improves residents' self-efficacy and clinical practice habits [0.03%]
一项有关肥胖治疗的课程能够提高住院医生的自我效能感以及临床实践习惯
Marci Laudenslager,Kacey Chae,Sean Tackett et al.
Marci Laudenslager et al.
Background: Most residency programs lack formal curricula on obesity care leaving physicians unprepared to treat obesity. After conducting a targeted needs assessment, we refined a previously developed online obesity care...
Systematic review of parental influence on pediatric obesity: Exploring dietary habits, physical activity, and intervention strategies [0.03%]
系统评价：父母对儿童肥胖的影响：探索饮食习惯、身体活动和干预策略
Surendra Gupta,Purushottam Lal,Rakesh Sharma et al.
Surendra Gupta et al.
Objectives: The purpose of this systematic review was to synthesize current evidence on the effectiveness of family-centered interventions that target parental behaviors such as dietary habits, physical activity, and sede...
Childhood obesity management in primary care: Bridging guidelines and practice [0.03%]
儿科肥胖管理：从指导原则到临床实践
Venkata Sushma Chamarthi,Jennifer Lynn McCauley,Evan P Nadler et al.
Venkata Sushma Chamarthi et al.
Introduction: Childhood obesity continues to escalate in prevalence and severity, affecting nearly one in five U.S. children. Severe obesity is the fastest-growing subcategory, with disproportionately high rates among ado...
Perceived benefits of treatment for obesity with retatrutide: A qualitative study of patients in a phase 2 clinical trial [0.03%]
利拉鲁肽治疗肥胖患者疗效的感知收益：一项二期临床试验患者的定性研究
Iris A Goetz,Chisom Kanu,Anastasia Hoover et al.
Iris A Goetz et al.
Background: Retatrutide, an agonist of glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon receptors, is in development for the treatment of obesity. We interviewed participants exiting a p...
The safety and efficacy of extended use of an oral shape-shifting superabsorbent hydrogel capsule for weight loss: The ELECT extension study [0.03%]
用于体重减轻的口服变形超强吸水凝胶胶囊长期使用的安全性和有效性：ELECT延展研究
Moshe Kamar,Donna H Ryan,Sharon Leonard et al.
Moshe Kamar et al.
Background: Long-term weight-loss maintenance remains challenging despite of the numerous available treatments. The previously published pivotal randomized RESET study demonstrated a mean weight reduction from baseline of...
Vicarious efficacy of tirzepatide in a cohabiting couple: An observational case report [0.03%]
tirzepatide 伴侣中的旁观者效益：一项观察性病例报告
Kieran Eason,Claire Feeney,Tim Killeen
Kieran Eason
Introduction: Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, produces substantial weight loss and glycaemic improvement in people with and with...
Case Reports
Obesity pillars. 2025 Oct 21:16:100219. DOI:10.1016/j.obpill.2025.100219 2025
Exploring the role of digital health technologies in assessing functional mobility and physical activity: Insights from qualitative interviews in adults with obesity or overweight [0.03%]
探索数字健康技术在评估肥胖或超重成人功能 Mobility 和物理活动中的作用：定性访谈的启示
Jeremiah J Trudeau,Brian Winger,Theresa Hunter Gibble et al.
Jeremiah J Trudeau et al.
Background: Digital health technologies (DHTs) offer passive, objective, and continuous monitoring of difficult-to-report mobility-related behaviors like physical activity (PA) and functional mobility (FM), which are impo...